ISRCTN27879030已完成未知
Cost benefit evaluation of routine influenza immunisation in subjects 65-74 years of age
Department of Health (UK)0 个研究点目标入组 729 人开始时间: 2003年4月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 729
研究概览
简要总结
2003 results in: https://www.ncbi.nlm.nih.gov/pubmed/14499051
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •65-74 year olds
排除标准
- •Aged over 75 years
研究者
相似试验
已完成
不适用
Prevention of Respiratory Infections and MAnagement among Children (PRIMAKid).NL-OMON27299The Netherlands Organization for Health Research and Development ZONMW (grant number 2200.0121)660
已完成
不适用
Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in RomeInfluenza VaccineCost-Benefit AnalysisNCT06304038Fondazione Policlinico Universitario Agostino Gemelli IRCCS5,483
已完成
3 期
Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM VaccineInfluenzaNCT00554333Sanofi Pasteur, a Sanofi Company795
已完成
4 期
Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid)Recurrent Upper and Lower Respiratory Tract Infections (RTIs)NCT00161122UMC Utrecht660
已完成
3 期
Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, QuadrivalentSeasonal InfluenzaNCT05431725Sinovac Biotech Co., Ltd2,202